News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
179 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38485)
2025 (22354)
Month
January (2946)
February (2976)
March (2714)
April (2913)
May (3636)
June (2415)
July (2091)
August (2663)
Day
2 (2)
3 (145)
4 (188)
5 (190)
6 (124)
7 (71)
10 (179)
11 (91)
12 (168)
13 (122)
14 (57)
17 (142)
18 (120)
19 (151)
20 (179)
21 (55)
24 (93)
25 (131)
26 (123)
27 (118)
28 (134)
31 (131)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
Day
2
3
4
5
6
7
10
11
12
13
14
17
18
19
20
21
24
25
26
27
28
31
Opinion
FDA Faces Challenging Decision on Biomarker-Based Label Restrictions
The FDA’s Oncologic Drugs Advisory Committee recently voted to narrow the label for checkpoint inhibitors Keytruda and Opdivo in stomach and esophageal cancers based on PD-L1 expression levels—but the high unmet need in these patient populations should also be considered.
March 10, 2025
·
5 min read
·
Harpreet Singh
Press Releases
Medicus Pharma Ltd. Announces Closing of $4.2 Million Regulation A Offering
March 10, 2025
·
5 min read
Press Releases
Redwire Corporation Reports Fourth Quarter and Full Year 2024 Financial Results
March 10, 2025
·
20 min read
Press Releases
Nyxoah to Release Fourth Quarter and Financial Year 2024 Financial Results on March 13, 2025
March 10, 2025
·
5 min read
Press Releases
I-Mab Announces Accelerated Givastomig Phase 1b Study Progress
March 10, 2025
·
5 min read
Press Releases
BioXcel Therapeutics Announces 33% Enrollment in SERENITY At-Home Pivotal Phase 3 Safety Trial for Acute Treatment of Agitation Associated with Bipolar Disorders or Schizophrenia
March 10, 2025
·
12 min read
Press Releases
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - March 7, 2025
March 10, 2025
·
2 min read
Press Releases
TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting
March 10, 2025
·
15 min read
Press Releases
Cogent Biosciences Announces Participation in the Leerink Healthcare Conference
March 10, 2025
·
2 min read
Press Releases
BIO-Europe Spring 2025: Partnering is Surging - All Roads Lead to Milan for Biopharma’s Premier Springtime Event
March 10, 2025
·
5 min read
Previous
2 of 18
Next
